Safety of Rimegepant in Patients Using Preventive Migraine Medications: A Subgroup Analysis of a Long-Term, Open-Label Study Conducted in the United States

Overview of attention for article published in Journal of Pain Research, May 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 1 X user

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 1 X post from an account with 6,905 followers.

View Pfizer’s migraine research, a new subgroup analysis of a long-term, open label study of a CGRP receptor antagonist in patients using preventive migraine medication in Journal of Pain Research. Click the link to read the article. #neurotwitter https://

11 Jun 2024

Reply Repost Favourite

Dove Medical Press

Article Metrics

Safety of Rimegepant in Patients Using Preventive Migraine Medications: A Subgroup Analysis of a Long-Term, Open-Label Study Conducted in the United States

About this Attention Score

Mentioned by

Readers on